• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.HIV临床试验中严重非艾滋病事件诊断标准的制定。
HIV Clin Trials. 2010 Jul-Aug;11(4):205-19. doi: 10.1310/hct1104-205.
2
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.与成人 HIV 感染者的非致命性 AIDS 和严重非 AIDS 事件相关的全因死亡率风险。
AIDS. 2010 Mar 13;24(5):697-706. doi: 10.1097/QAD.0b013e3283365356.
3
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials.两项多中心国际临床试验中与HIV相关临床终点的报告与评估
HIV Clin Trials. 2006 May-Jun;7(3):125-41. doi: 10.1310/7MER-XFA7-1762-E2WR.
4
Grade 4 events are as important as AIDS events in the era of HAART.在高效抗逆转录病毒治疗(HAART)时代,4级事件与艾滋病事件同样重要。
J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):379-86. doi: 10.1097/00126334-200312010-00004.
5
Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.慢性阻塞性肺疾病患者心血管事件的裁定:SUMMIT 试验。
Clin Trials. 2020 Aug;17(4):430-436. doi: 10.1177/1740774520920897. Epub 2020 May 22.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Determination of the underlying cause of death in three multicenter international HIV clinical trials.三项多中心国际艾滋病临床试验中潜在死因的判定
HIV Clin Trials. 2008 May-Jun;9(3):177-85. doi: 10.1310/hct0903-177.
8
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era.在高效抗逆转录病毒治疗(HAART)时代进行HIV感染临床终点试验的可行性。
Clin Trials. 2006;3(2):119-32. doi: 10.1191/1740774506cn138oa.
9
How does HIV impact on non-AIDS events in the era of HAART?在高效抗逆转录病毒治疗(HAART)时代,艾滋病病毒(HIV)如何影响非艾滋病相关事件?
Int J STD AIDS. 2009 Jan;20(1):1-3. doi: 10.1258/ijsa.2008.008302.
10
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.

引用本文的文献

1
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort.一种用于多民族和多种族 HIV+队列心血管疾病的蛋白质风险评分的推导。
J Am Heart Assoc. 2023 Jul 4;12(13):e027273. doi: 10.1161/JAHA.122.027273. Epub 2023 Jun 22.
2
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.HIV感染中早期启动抗逆转录病毒治疗的长期益处。
NEJM Evid. 2023 Mar;2(3). doi: 10.1056/evidoa2200302. Epub 2023 Feb 27.
3
Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States.与来自非洲和美国的 HIV 病毒抑制成人免疫无应答相关的临床因素和结局。
Sci Rep. 2022 Jan 24;12(1):1196. doi: 10.1038/s41598-022-04866-z.
4
A randomized evaluation of on-site monitoring nested in a multinational randomized trial.现场监测在跨国随机试验中的嵌套随机评估
Clin Trials. 2020 Feb;17(1):3-14. doi: 10.1177/1740774519881616. Epub 2019 Oct 24.
5
Computerized Adjudication of Coronary Heart Disease Events Using the Electronic Medical Record in HIV Clinical Research: Possibilities and Challenges Ahead.利用电子病历进行 HIV 临床研究中心血管疾病事件的计算机化裁定:未来的可能性和挑战。
AIDS Res Hum Retroviruses. 2020 Apr;36(4):306-313. doi: 10.1089/AID.2019.0036. Epub 2019 Sep 10.
6
The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis.中断/延迟抗逆转录病毒治疗对疾病风险的影响:SMART 和 START 联合分析。
J Infect Dis. 2019 Jan 7;219(2):254-263. doi: 10.1093/infdis/jiy442.
7
Serious Non-AIDS Conditions in HIV: Benefit of Early ART.HIV 相关严重非艾滋病状况:早期 ART 的获益。
Curr HIV/AIDS Rep. 2018 Apr;15(2):162-171. doi: 10.1007/s11904-018-0387-y.
8
Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital.在穆拉戈医院门诊就诊的成年 HIV 阳性患者中下肢深静脉血栓形成的患病率。
AIDS Res Ther. 2018 Jan 25;15(1):3. doi: 10.1186/s12981-018-0191-1.
9
Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy.在澳大利亚接受抑制性抗逆转录病毒疗法的成年人中,同时服用多种药物、药物相互作用和不完全遵医嘱的情况很常见。
AIDS. 2018 Jan 2;32(1):35-48. doi: 10.1097/QAD.0000000000001685.
10
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.洛匹那韦利托那韦加核苷逆转录酶抑制剂、洛匹那韦利托那韦加雷特格韦或洛匹那韦单药治疗二线 HIV(EARNEST):一项随机对照试验的 144 周随访结果。
Lancet Infect Dis. 2018 Jan;18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8. Epub 2017 Nov 3.

本文引用的文献

1
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.HIV 感染者在抗逆转录病毒治疗临床试验中的与吸烟相关的健康风险。
Am J Public Health. 2010 Oct;100(10):1896-903. doi: 10.2105/AJPH.2009.188664. Epub 2010 Aug 19.
2
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.成人 HIV 感染的抗逆转录病毒治疗:国际艾滋病协会-美国小组 2010 年的建议。
JAMA. 2010 Jul 21;304(3):321-33. doi: 10.1001/jama.2010.1004.
3
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.D:A:D 研究中 HIV 阳性个体特定死因相关因素。
AIDS. 2010 Jun 19;24(10):1537-48. doi: 10.1097/QAD.0b013e32833a0918.
4
Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.1996-2006 年抗逆转录病毒治疗的 HIV-1 感染者的死亡原因:13 项 HIV 队列研究的协作分析。
Clin Infect Dis. 2010 May 15;50(10):1387-96. doi: 10.1086/652283.
5
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.拉丁美洲地区 HIV 感染成年人严重非艾滋病事件分析。
HIV Med. 2010 Oct 1;11(9):554-64. doi: 10.1111/j.1468-1293.2010.00824.x. Epub 2010 Mar 21.
6
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.HIV 感染患者抗逆转录病毒治疗与未治疗的止血平衡:抗逆转录病毒治疗部分恢复。
AIDS Patient Care STDS. 2009 Dec;23(12):1001-7. doi: 10.1089/apc.2009.0173.
7
Interleukin-2 therapy in patients with HIV infection.白细胞介素-2疗法用于HIV感染患者。
N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.
8
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.对HIV感染者中非艾滋病相关癌症发病率的荟萃分析。
J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22. doi: 10.1097/QAI.0b013e3181b327ca.
9
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染患者中炎症标志物、内皮激活标志物与颈动脉内膜中层厚度之间的关系。
Clin Infect Dis. 2009 Oct 1;49(7):1119-27. doi: 10.1086/605578.
10
Update on cardiovascular complications in HIV infection.HIV感染中心血管并发症的最新情况。
Top HIV Med. 2009 Jul-Aug;17(3):98-103.

HIV临床试验中严重非艾滋病事件诊断标准的制定。

Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

作者信息

Lifson Alan R, Belloso Waldo H, Davey Richard T, Duprez Daniel, Gatell Jose M, Hoy Jennifer F, Krum Eric A, Nelson Ray, Pedersen Court, Perez George, Price Richard W, Prineas Ronald J, Rhame Frank S, Sampson James H, Worley John

机构信息

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota 55454-1015, USA.

出版信息

HIV Clin Trials. 2010 Jul-Aug;11(4):205-19. doi: 10.1310/hct1104-205.

DOI:10.1310/hct1104-205
PMID:20974576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109979/
Abstract

PURPOSE

Serious non-AIDS (SNA) diseases are important causes of morbidity and mortality in the HAART era. We describe development of standard criteria for 12 SNA events for Endpoint Review Committee (ERC) use in START, a multicenter international HIV clinical trial.

METHODS

SNA definitions were developed based upon the following: (1) criteria from a previous trial (SMART), (2) review of published literature, (3) an iterative consultation and review process with the ERC and other content experts, and (4) evaluation of draft SNA criteria using retrospectively collected reports in another trial (ESPRIT).

RESULTS

Final criteria are presented for acute myocardial infarction, congestive heart failure, coronary artery disease requiring drug treatment, coronary revascularization, decompensated liver disease, deep vein thrombosis, diabetes mellitus, end-stage renal disease, non-AIDS cancer, peripheral arterial disease, pulmonary embolism, and stroke. Of 563 potential SNA events reported in ESPRIT and reviewed by an ERC, 72% met "confirmed" and 13% "probable" criteria. Twenty-eight percent of cases initially reviewed by the ERC required follow-up discussion (adjudication) before a final decision was reached.

CONCLUSION

HIV clinical trials that include SNA diseases as clinical outcomes should have standardized SNA definitions to optimize event reporting and validation and should have review by an experienced ERC with opportunities for adjudication.

摘要

目的

在高效抗逆转录病毒治疗(HAART)时代,严重非艾滋病(SNA)疾病是发病和死亡的重要原因。我们描述了用于终点审查委员会(ERC)在START(一项多中心国际HIV临床试验)中使用的12种SNA事件的标准准则的制定情况。

方法

SNA定义基于以下内容制定:(1)先前一项试验(SMART)的标准;(2)对已发表文献的回顾;(3)与ERC及其他内容专家进行的反复咨询和审查过程;(4)使用另一项试验(ESPRIT)中回顾性收集的报告对SNA标准草案进行评估。

结果

给出了急性心肌梗死、充血性心力衰竭、需要药物治疗的冠状动脉疾病、冠状动脉血运重建、失代偿性肝病、深静脉血栓形成、糖尿病、终末期肾病、非艾滋病相关癌症、外周动脉疾病、肺栓塞和中风的最终标准。在ESPRIT中报告并经ERC审查的563起潜在SNA事件中,72%符合“确诊”标准,13%符合“可能”标准。ERC最初审查的病例中有28%在做出最终决定前需要后续讨论(裁定)。

结论

将SNA疾病作为临床结局的HIV临床试验应具有标准化的SNA定义,以优化事件报告和验证,并且应由经验丰富的ERC进行审查并有裁定机会。